Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Pennypacker, L. C.
space
  arrow  Pitner, J.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Hyperkalemia in Elderly Patients Receiving Standard Doses of Trimethoprim-Sulfamethoxazole

right arrow Leslye C. Pennypacker, MD; Jacobo Mintzer, MD; and Janet Pitner, PharmD

1 March 1994 | Volume 120 Issue 5 | Pages 437-438


TO THE EDITOR:

We read with great interest the recently reported [1] association between high-dose trimethoprim-sulfamethoxazole therapy and hyperkalemia seen in patients with AIDS. Although our patient population differs substantially from that studied by Greenberg and colleagues [1], we have seen a similar clinical course evolve in an elderly, cognitively impaired patient who was being treated for a urinary tract infection. Our patient, a 76-year-old woman, presented with normal serum electrolyte levels (sodium, 136 mmol/L; potassium, 4.5 mmol/L; HCO3, 24 mmol/L; chlorine, 108 mmol/L; blood urea nitrogen, 23 mg/dL; and creatinine, 1.1 mg/dL) and no known history of renal, endocrine, or metabolic abnormalities. At admission, urinalysis was similarly unremarkable with the exception of pyuria and bacteruria. Subsequent culture yielded a pan-sensitive Klebsiella species, and the patient was given trimethoprim-sulfamethoxazole (Septra-DS; Burroughs Wellcome, Research Triangle Park, North Carolina), one tablet twice daily, beginning on hospital day 3. One week later, her mental status declined acutely, and her electrolytes showed a serum potassium level of 6.2 mmol/L, without evidence of azotemia, acidosis, or dehydration. The patient had not received any other known nephrotoxic medications during this period. Her urinary sediment continued to be unremarkable. Therapy with trimethoprim-sulfamethoxazole was discontinued, and the patient was treated with one dose of kayexalate. Her serum potassium level returned to normal and remained so for the duration of her 3-week hospitalization.

To our knowledge, no available data exist on the incidence of hyperkalemia in geriatric patients receiving standard adult doses of this commonly used antibiotic. Although the mechanism by which trimethoprim-sulfamethoxazole induces hyperkalemia remains unclear, does the age-associated decrease in the glomerular filtration rate place our elderly patients at higher risk for a dose-dependent, potentially fatal complication? Until additional data are available, we suggest using this antibiotic treatment with greater caution in elderly patients.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowREFERENCE

Medical University of South Carolina; Charleston, SC 29425


REFERENCE
space
up arrowTop
up arrowAuthor & Article Info
dotREFERENCE

1. Greenberg S, Reiser IW, Chou SY, Porush JG. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia. Ann Intern Med. 1993; 119:291-5.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Pennypacker, L. C.
space
  arrow  Pitner, J.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online